The acquisition enhances Novonesis' ability to serve pork and livestock producers with a broader portfolio of enzyme and probiotic solutions. By incorporating dsm-firmenich's sales and distribution activities into its already strong innovation and production pipeline, Novonesis will now operate as a fully integrated business across the entire value chain.